相关实验视频

Updated: Jul 10, 2025

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

工程治疗性单克隆抗体的工程

Cosby A Stone¹, Benjamin W Spiller², Scott A Smith³

¹Department of Medicine, Vanderbilt University Medical Center, Nashville, Tenn.

The Journal of allergy and clinical immunology

|November 23, 2023

概括

工程人类抗体提供了巨大的治疗潜力,彻底改变医学. 抗体工程的进步提高了疗效,安全性和半衰期,推动了市场的显著增长.

科学领域:

生物技术是生物技术.
免疫学免疫学免疫学
药理学药理学是指药理学的学科.

背景情况:

人类抗体是关键的生物疗法,改变了医疗领域的患者护理.
了解免疫反应中的抗体功能,推动了新的治疗应用的发展.

研究的目的:

探索优化人类抗体作为治疗药物的工程策略.
突出抗体工程在扩大治疗指示和改善药物特性方面的潜力.

主要方法:

利用来自人类B细胞或工程小鼠的全人类变量区域.
采用亲和力成熟,突变发生和in silico方法来优化特异性.
工程抗体同型和Fc受体结合,以提高疗效,耐受性和半衰期.

主要成果:

工程抗体表现出增强的免疫功能和减少不良影响.
优化技术显著提高了抗体特异性和效应器功能.
新生儿Fc受体结合的修改大大延长了循环半衰期.

结论:

人类抗体的理性工程提供了广泛的治疗可能性.
抗体工程的进步有望扩大其临床应用和市场价值.
工程抗体治疗药物市场预计将大幅增长,到2030年将达到近半万亿美元.

关键词:

过敏过敏是一种过敏.在 IgE 中,IgE 是抗体工程是针对抗体的工程.免疫学免疫学免疫学 mAbAb 在线观看治疗性抗体治疗性抗体

更多相关视频

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research

Published on: September 16, 2019

A Three-dimensional Thymic Culture System to Generate Murine Induced Pluripotent Stem Cell-derived Tumor Antigen-specific Thymic Emigrants

A Three-dimensional Thymic Culture System to Generate Murine Induced Pluripotent Stem Cell-derived Tumor Antigen-specific Thymic Emigrants

Published on: August 9, 2019

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Hybridoma Technology

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...